{
  "meta": {
    "timestamp": "2025-01-06T08:01:53.053784",
    "version": "1.0",
    "type": "search_analysis"
  },
  "companies": [
    {
      "company_name": "CENCORA INC COM",
      "symbol": "COR",
      "analysis": {
        "historical": {
          "risk_score": 65,
          "key_risks": [
            "Opioid litigation and settlements",
            "Regulatory and compliance risks",
            "Cybersecurity vulnerabilities",
            "Supply chain disruptions"
          ],
          "controversies": [
            "$300 million class action settlement related to opioid crisis",
            "$266 million damages in Baltimore opioid lawsuit",
            "February 2024 cyberattack resulting in data exfiltration"
          ],
          "environmental_issues": [
            "Reliance on a complex global supply chain vulnerable to disruptions",
            "Initiatives to reduce carbon footprint and improve environmental practices"
          ],
          "social_issues": [
            "Role in opioid crisis and associated legal challenges",
            "Engagement with medical ethicists during supply shortages"
          ],
          "governance_issues": [
            "Compliance obligations under the Drug Supply Chain Security Act (DSCSA)",
            "Scrutiny over supply chain practices"
          ],
          "recommendation": "caution",
          "confidence_score": 80
        },
        "evidence": {
          "sources": [
            {
              "url": "",
              "title": "Cencora, Inc. - Distributors Approve Opioid Settlement Agreement",
              "snippet": "As of February 25, 2022, more than 90 percent of eligible political subdivisions that have brought opioid-related suits against the companies, as calculated by population under the agreement, have agreed to participate in the settlement or have had their claims addressed by state legislation. The settlement will provide thousands of",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "CENCORA INC COM CENCORA INC COM opioid litigation settlements",
              "retrieved_at": "2025-01-06T15:01:16.832123+00:00",
              "published_date": null,
              "source_hash": "2a4c93d9fbde9536ef94f3f3688bd969"
            },
            {
              "url": "",
              "title": "McKesson, Cardinal, Cencora to pay $300M settlement over role in opioid ...",
              "snippet": "Three of the country's largest drug distributors have reached a $300 million class action settlement over allegations they contributed to the opioid crisis, Reuters reports. McKesson Corp., Cencora Inc. and Cardinal Health deny any wrongdoing but agreed to settle the McKesson opioid class action lawsuit to escape claims from health insurance companies and benefit plans over the drug ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "CENCORA INC COM CENCORA INC COM opioid litigation settlements",
              "retrieved_at": "2025-01-06T15:01:16.832397+00:00",
              "published_date": null,
              "source_hash": "fca7a52c57892f7ad87866c481fe5755"
            },
            {
              "url": "",
              "title": "Cencora, Inc. - Distributors Announce Proposed Opioid Settlement Agreement",
              "snippet": "AmerisourceBergen (NYSE: ABC), Cardinal Health (NYSE: CAH) and McKesson (NYSE: MCK) announced today that they have negotiated a comprehensive proposed settlement agreement which, if all conditions are satisfied, would result in the settlement of a substantial majority of opioid lawsuits filed by state and local governmental entities. While the companies strongly dispute the allegations made in ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "CENCORA INC COM CENCORA INC COM opioid litigation settlements",
              "retrieved_at": "2025-01-06T15:01:16.832461+00:00",
              "published_date": null,
              "source_hash": "a440c4cd1860ec5c55a0f2376779d6de"
            },
            {
              "url": "",
              "title": "Distributors announce proposed opioid settlement | Cencora",
              "snippet": "Under the proposed settlement agreement and process, all U.S. States, territories, and Washington DC were given 30 days to join the settlement, except West Virginia which settled previously with the companies. As of August 21, 2021, 42 out of 49 states, all 5 territories and Washington DC had affirmatively signed on to the agreement.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "CENCORA INC COM CENCORA INC COM opioid litigation settlements",
              "retrieved_at": "2025-01-06T15:01:16.832479+00:00",
              "published_date": null,
              "source_hash": "487e7eafde351cf868d034aa2a855cda"
            },
            {
              "url": "",
              "title": "Distributors Reach Settlement With Ohio Counties in Opioids Case",
              "snippet": "CLEVELAND - AmerisourceBergen (NYSE: ABC), Cardinal Health (NYSE: CAH) and McKesson (NYSE: MCK) announced this morning that they have agreed to a $215 million settlement with two Ohio counties, Cuyahoga and Summit, in the first track of the multi-district opioid litigation.With this settlement agreed upon, the companies and the other parties will now continue the work toward a global resolution.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "CENCORA INC COM CENCORA INC COM opioid litigation settlements",
              "retrieved_at": "2025-01-06T15:01:16.832491+00:00",
              "published_date": null,
              "source_hash": "4ac07911fb664f92b759eb0b3a5388a8"
            },
            {
              "url": "",
              "title": "Cencora, Inc. - Distributors Reach Opioid Settlement Agreement With New ...",
              "snippet": "AmerisourceBergen (NYSE: ABC), Cardinal Health (NYSE: CAH) and McKesson (NYSE: MCK) announced today that they have agreed to pay up to $1.179 billion in a settlement with the State of New York and its participating subdivisions, including Nassau and Suffolk Counties, to resolve opioid-related claims. This settlement was negotiated in connection with the ongoing negotiations toward a broad ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "CENCORA INC COM CENCORA INC COM opioid litigation settlements",
              "retrieved_at": "2025-01-06T15:01:16.832502+00:00",
              "published_date": null,
              "source_hash": "aa12de5e2b532bdf1c16ac6fbefc4a2b"
            },
            {
              "url": "",
              "title": "Drug Distributors Agree to Pay $300 Million to Health Plans",
              "snippet": "The nation's three largest drug distributors - McKesson Corp, Cardinal Health Inc, and Cencora Inc - recently agreed to pay $300 million to health plans to settle lawsuits over their role in the opioid epidemic. The lawsuits resolved by this settlement were those brought by private benefit plans that provide health and welfare benefits to members and their families, including ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "CENCORA INC COM CENCORA INC COM opioid litigation settlements",
              "retrieved_at": "2025-01-06T15:01:16.832517+00:00",
              "published_date": null,
              "source_hash": "9d3b12cedfa1481b6e31edd755fee4d7"
            },
            {
              "url": "",
              "title": "Opioid Settlement: Drug Distributors McKesson, Cencora ... - Benzinga",
              "snippet": "Three major U.S. drug distributors, McKesson, Cencora, and Cardinal Health, have agreed to a $300 million settlement over claims by health insurers and benefit plans that they contributed to the ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "CENCORA INC COM CENCORA INC COM opioid litigation settlements",
              "retrieved_at": "2025-01-06T15:01:16.832528+00:00",
              "published_date": null,
              "source_hash": "7b92743edb62cea28c4f0fd4f94f8c6f"
            },
            {
              "url": "",
              "title": "Combating the Opioid Epidemic | ESG - Cencora",
              "snippet": "In FY22, Cencora, along with two other pharmaceutical distributors, agreed to a nationwide settlement that resolves a substantial majority of the opioid-related lawsuits filed by state and local government entities across the country. In FY23, we have also entered into separate settlements with West Virginia subdivisions and Native American tribes.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "CENCORA INC COM CENCORA INC COM opioid litigation settlements",
              "retrieved_at": "2025-01-06T15:01:16.832553+00:00",
              "published_date": null,
              "source_hash": "cd1cd0567746ac36bda52fc247e42569"
            },
            {
              "url": "",
              "title": "Drug distributors strike $300 million opioid settlement with US health ...",
              "snippet": "The proposed class action settlement with McKesson Corp, Cencora Inc and Cardinal Health Inc was disclosed in a filing in federal court in Cleveland, Ohio, and requires a judge's approval.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "CENCORA INC COM CENCORA INC COM opioid litigation settlements",
              "retrieved_at": "2025-01-06T15:01:16.832564+00:00",
              "published_date": null,
              "source_hash": "ce8983ffdfba9e205b0a79c6f5f44695"
            },
            {
              "url": "",
              "title": "McKesson, Cencora slapped with $266M in damages in Baltimore opioid lawsuit",
              "snippet": "Leading medical distributors McKesson (NYSE:MCK) and Cencora ... a lawsuit that began six years ago. In its lawsuit, Baltimore accused the duo of ignoring its warnings that the opioids they ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "CENCORA INC COM CENCORA INC COM opioid litigation settlements",
              "retrieved_at": "2025-01-06T15:01:20.916105+00:00",
              "published_date": "2024-11-13T18:35:00+00:00",
              "source_hash": "0889043ff24cef8d38d88e607f21cae0"
            },
            {
              "url": "",
              "title": "Cencora Completes Acquisition of Retina Consultants of America",
              "snippet": "Cencora, Inc. (NYSE: COR) today announced the completion of its previously announced acquisition of Retina Consultants of America (\"RCA\"), a leading m",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "CENCORA INC COM CENCORA INC COM opioid litigation settlements",
              "retrieved_at": "2025-01-06T15:01:20.916081+00:00",
              "published_date": "2025-01-03T01:15:00+00:00",
              "source_hash": "5be9940dd77f4bcaadc68efa57bd5ac0"
            },
            {
              "url": "",
              "title": "Cencora Breaks Below 200-Day Moving Average - Notable for COR",
              "snippet": "In trading on Wednesday, shares of Cencora Inc (Symbol: COR) crossed below their 200 day moving average of $234.00, changing hands as low as $231.44 per share. Cencora Inc shares are currently ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "CENCORA INC COM CENCORA INC COM opioid litigation settlements",
              "retrieved_at": "2025-01-06T15:01:20.916095+00:00",
              "published_date": "2024-12-11T16:05:00+00:00",
              "source_hash": "92256a4dd676648c90aaf3f9fc2c021e"
            },
            {
              "url": "",
              "title": "Pharmaceutical giants to pay Baltimore $266M in opioid epidemic lawsuit",
              "snippet": "Baltimore opted out of a national settlement with pharmaceutical companies over opioid addiction to ... The Justice Department also filed a lawsuit against Cencora in December 2022.",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "CENCORA INC COM CENCORA INC COM opioid litigation settlements",
              "retrieved_at": "2025-01-06T15:01:20.916115+00:00",
              "published_date": "2024-11-16T02:22:00+00:00",
              "source_hash": "519adced4bb2ebcc59cbe152fd1e5bf6"
            },
            {
              "url": "",
              "title": " Drug Supply Chain Security Act - AmerisourceBergen",
              "snippet": "Failure to do so is a compliance violation of the intent of the FDA compliance policy which also puts Cencora at a regulatory riskof non -compliance. March 31, 2024: Cencora fully expects 100% of all sales to contain serialized databy the end of March. We need this to ensure the ability to facilitate verification against replicate data and to ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "CENCORA INC COM CENCORA INC COM regulatory compliance failures",
              "retrieved_at": "2025-01-06T15:01:24.172891+00:00",
              "published_date": null,
              "source_hash": "ed4889909a419f332ef7c5a21c0ceaa2"
            },
            {
              "url": "",
              "title": "Cencora Cyberattack Affects Pharmaceutical Companies",
              "snippet": "Cencora, Inc. (earlier known as AmerisourceBergen), and its Lash Group affiliate, were impacted by a cyberattack. Cencora reported the incident in a Securities and Exchange Commission (SEC) filing in February 2024. During that time, the scope of the data breach is not yet confirmed though Cencora reported in the SEC filing the exfiltration of data [\u2026]",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "CENCORA INC COM CENCORA INC COM regulatory compliance failures",
              "retrieved_at": "2025-01-06T15:01:24.172919+00:00",
              "published_date": null,
              "source_hash": "e84a6be32fa1a53dd33685a5dd985654"
            },
            {
              "url": "",
              "title": "Cencora Inc. (via Public) / Prioritizing DSCSA Adherence to Protect ...",
              "snippet": "Matthew Sample, SVP, Manufacturer and Replenishment Operations, Cencora (formerly AmerisourceBergen) On August 25, the U.S. Food and Drug Administration (FDA) announced that it will delay its enforcement of the Drug Supply Chain Security Act (DSCSA) until November 2024, providing manufacturers, distributors, dispensers and other trading partners a year-long \"stabilization period\" to comply ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "CENCORA INC COM CENCORA INC COM regulatory compliance failures",
              "retrieved_at": "2025-01-06T15:01:24.172927+00:00",
              "published_date": null,
              "source_hash": "095ee7c45f898e1a096d9c2b64afdc22"
            },
            {
              "url": "",
              "title": " Cencora position on FDA's October DSCSA exemption announcement",
              "snippet": "\u2022 Cencora will begin physically quarantining products received without the required DSCSA EPCIS data. Notifications will continue but will indicate that the product is now quarantined until the issue is resolved. \u2022 By end of May, Cencora will stop relying on the ASN as DSCSA regulatory document (manufacturers will be switching to ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "CENCORA INC COM CENCORA INC COM regulatory compliance failures",
              "retrieved_at": "2025-01-06T15:01:24.172931+00:00",
              "published_date": null,
              "source_hash": "7b11a5e51b7c7edd7b3a1c05e05d7295"
            },
            {
              "url": "",
              "title": "Prioritizing DSCSA Adherence to Protect Patient Safety | Cencora",
              "snippet": "Matthew Sample, SVP, Manufacturer and Replenishment Operations, Cencora (formerly AmerisourceBergen) On August 25, the U.S. Food and Drug Administration (FDA) announced that it will delay its enforcement of the Drug Supply Chain Security Act (DSCSA) until November 2024, providing manufacturers, distributors, dispensers and other trading partners a year-long \"stabilization period\" to comply ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "CENCORA INC COM CENCORA INC COM regulatory compliance failures",
              "retrieved_at": "2025-01-06T15:01:24.172936+00:00",
              "published_date": null,
              "source_hash": "71f80137fae2bf679ad72df915a589d6"
            },
            {
              "url": "",
              "title": "DSCSA Compliance Amid FDA Exemptions | Cencora",
              "snippet": "On October 9, 2024, the Food and Drug Administration (FDA) issued an exemption for eligible trading partners that will continue to delay enforcement regarding compliance with the Drug Supply Chain Security Act's (DSCSA) final enhanced drug distribution security requirements. The exemption duration varies by partner type: Manufacturers and Repackagers: Until May 27, 2025",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "CENCORA INC COM CENCORA INC COM regulatory compliance failures",
              "retrieved_at": "2025-01-06T15:01:24.172939+00:00",
              "published_date": null,
              "source_hash": "facef91fe06f659369acd61eaa983639"
            },
            {
              "url": "",
              "title": "Drug Supply Chain Security Act: How Cencora supports compliance",
              "snippet": "Cencora is also making efforts to ensure that all partners are exchanging DSCSA data ahead of the 2025 deadlines for companies with exemptions. Currently, all of Cencora's distribution centers are active and capturing inbound and outbound data, and the healthcare company is already receiving more than 90% of data from its manufacturers.",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "CENCORA INC COM CENCORA INC COM regulatory compliance failures",
              "retrieved_at": "2025-01-06T15:01:24.172943+00:00",
              "published_date": null,
              "source_hash": "8ebccfd0636e65365eceef018b79f43c"
            },
            {
              "url": "",
              "title": "Ethics and compliance - Cencora",
              "snippet": "Cencora's Compliance Program reinforces the core elements of our approach through annual compliance training for all team members. In addition, we supplemented this Global Training with targeted trainings for employees based on their roles and responsibilities. To provide additional support, we celebrated Compliance and Ethics Week throughout ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "CENCORA INC COM CENCORA INC COM regulatory compliance failures",
              "retrieved_at": "2025-01-06T15:01:24.172947+00:00",
              "published_date": null,
              "source_hash": "d759222dbd9e539a19da8aa033f9e2aa"
            },
            {
              "url": "",
              "title": "Cencora, Inc. - Governance - Policies",
              "snippet": "At Cencora, we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the 'unsubscribe' section below. If you experience any issues with this process, please contact us for further assistance.",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "CENCORA INC COM CENCORA INC COM regulatory compliance failures",
              "retrieved_at": "2025-01-06T15:01:24.172950+00:00",
              "published_date": null,
              "source_hash": "dceb2ae5032a729cc997c5d555423b2a"
            },
            {
              "url": "",
              "title": "Cencora - Quality Assurance and Compliance - The Org",
              "snippet": "The Quality Assurance and Compliance team at Cencora is responsible for ensuring that all pharmaceutical products and services meet the highest standards of quality and regulatory compliance. This team conducts rigorous audits, develops quality control processes, and collaborates with various stakeholders to uphold safety and efficacy in ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "CENCORA INC COM CENCORA INC COM regulatory compliance failures",
              "retrieved_at": "2025-01-06T15:01:24.172954+00:00",
              "published_date": null,
              "source_hash": "a884b44b27bf404113d1b9428553b255"
            },
            {
              "url": "",
              "title": "Green Supply Chains Prevail Amid Global Disruptions - Cencora",
              "snippet": "In addition to shutdowns, backlogs and the worker shortage, natural disasters created additional havoc for the supply chain in the last year, an element that can be combatted through green initiatives like those that our winners created. For the full article, please visit Supply & Demand Chain Executive.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "CENCORA INC COM CENCORA INC COM supply chain disruptions impact",
              "retrieved_at": "2025-01-06T15:01:28.394930+00:00",
              "published_date": null,
              "source_hash": "7a1af9cda06ccba4e05029e17e1a6ee2"
            },
            {
              "url": "",
              "title": "Supply Chain and Stewardship | ESG - Cencora",
              "snippet": "We engage a medical ethicist to provide guidance regarding product distribution practices in the case of shortages or other distribution challenges. In FY23, Cencora began working with nonprofit Civica as their exclusive distributor and to provide supply chain support to ensure the stability of supply of essential generic medicines across the U.S.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "CENCORA INC COM CENCORA INC COM supply chain disruptions impact",
              "retrieved_at": "2025-01-06T15:01:28.395070+00:00",
              "published_date": null,
              "source_hash": "998e205f0ec285554f1b66a08a76c644"
            },
            {
              "url": "",
              "title": "Cencora Breach - Supply Chain Attacks on Pharmaceuticals - Sotero",
              "snippet": "Endo Pharmaceuticals Inc. Dendreon Pharmaceuticals LLC; The impact of this attack demonstrates quite clearly how threat actors have used service providers like Cencora to spread throughout the supply chain and compromise many other organizations. Overview of the Cencora Attack. Back in March, we wrote about the initial filing of the Cencora ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "CENCORA INC COM CENCORA INC COM supply chain disruptions impact",
              "retrieved_at": "2025-01-06T15:01:28.395105+00:00",
              "published_date": null,
              "source_hash": "0c02eb2ed55797c01f7fec11d0dd5850"
            },
            {
              "url": "",
              "title": "Drug Supply Chain Security Act: How Cencora supports compliance",
              "snippet": "Drug Supply Chain Security Act: How Cencora supports compliance ... continue to test and validate their current systems and establish risk management plans in case there are any possible disruptions or informational gaps. ... but customers have options to limit the impact, experts say. By Max Garland \u2022 Oct. 15, 2024 Get the free newsletter ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "CENCORA INC COM CENCORA INC COM supply chain disruptions impact",
              "retrieved_at": "2025-01-06T15:01:28.395132+00:00",
              "published_date": null,
              "source_hash": "cf043ac43c4248314ff1c8105ed01456"
            },
            {
              "url": "",
              "title": "Cencora Inc (COR) (Q2 2024) Earnings Call Transcript Highlights: Robust ...",
              "snippet": "Explore key financial outcomes and strategic directions from Cencora Inc's Q2 2024 earnings call. ... role as a trusted partner in the pharmaceutical supply chain. ... disruptions in the ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "CENCORA INC COM CENCORA INC COM supply chain disruptions impact",
              "retrieved_at": "2025-01-06T15:01:28.395166+00:00",
              "published_date": null,
              "source_hash": "72bb4a152960c8bb16097dd9492c6d2c"
            },
            {
              "url": "",
              "title": "Navigating Global Health Challenges | ESG | Cencora",
              "snippet": "Cencora's purpose drives us to action during supply disruptions. We collaborate across the supply chain and work with our suppliers, industry groups, nonprofits, government agencies, and our customers to advocate for patients. We also offer programs, like Sure Supply to support health systems' access to high-risk or sensitive items.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "CENCORA INC COM CENCORA INC COM supply chain disruptions impact",
              "retrieved_at": "2025-01-06T15:01:28.395191+00:00",
              "published_date": null,
              "source_hash": "72c63d24596477fe871583f2d147c1e6"
            },
            {
              "url": "",
              "title": "Environmentally Aware | ESG | Cencora",
              "snippet": "We are committed to reducing waste through source reduction, recycling, and other innovative solutions. In FY23, Cencora continued offering a short-dated medication specials solution, which offers customers access to products nearing their expiration date at a discounted price to reduce supply chain waste.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "CENCORA INC COM CENCORA INC COM supply chain disruptions impact",
              "retrieved_at": "2025-01-06T15:01:28.395214+00:00",
              "published_date": null,
              "source_hash": "d5097c93ebcf9aef2a6605e8776ec199"
            },
            {
              "url": "",
              "title": "Cencora, Inc. Navigates Complex Risks: Health Crises, Natural ... - Nasdaq",
              "snippet": "Cencora, Inc. (COR) has disclosed a new risk, in the Natural and Human Disruptions category.Don't Miss our Black Friday Offers:Unlock your investing potential with TipRanks Premium - Now At 40% ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "CENCORA INC COM CENCORA INC COM supply chain disruptions impact",
              "retrieved_at": "2025-01-06T15:01:28.395236+00:00",
              "published_date": null,
              "source_hash": "96506943aeb73b3e2be6d42a5e97d8a3"
            },
            {
              "url": "",
              "title": "Cencora's Strategic Innovations Enhance Supply Chain Amidst Neutral ...",
              "snippet": "Lutz covers the Healthcare sector, focusing on stocks such as Hims & Hers Health, Teladoc, and Cencora. According to TipRanks , Lutz has an average return of 5.4% and a 58.60% success rate on ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "CENCORA INC COM CENCORA INC COM supply chain disruptions impact",
              "retrieved_at": "2025-01-06T15:01:28.395257+00:00",
              "published_date": null,
              "source_hash": "338eabc7366c09109ca163025c2f2844"
            },
            {
              "url": "",
              "title": "Decoding Cencora Inc (COR): A Strategic SWOT Insight - Yahoo Finance",
              "snippet": "On November 21, 2023, Cencora Inc , a leading pharmaceutical wholesaler, filed its 10-K report, revealing a year of substantial financial growth and strategic expansion. The company reported a ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "CENCORA INC COM CENCORA INC COM supply chain disruptions impact",
              "retrieved_at": "2025-01-06T15:01:28.395279+00:00",
              "published_date": null,
              "source_hash": "f70acead21790df1081b46cecaa89a99"
            }
          ],
          "queries": [
            {
              "category": "financial_legal",
              "query": "CENCORA INC COM opioid litigation settlements",
              "rationale": "Investigate legal outcomes and financial impacts of opioid-related lawsuits",
              "priority": 1
            },
            {
              "category": "ethical_social",
              "query": "CENCORA INC COM regulatory compliance failures",
              "rationale": "Assess the company's history with regulatory bodies and any ethical concerns",
              "priority": 2
            },
            {
              "category": "financial_legal",
              "query": "CENCORA INC COM supply chain disruptions impact",
              "rationale": "Explore financial risks associated with supply chain vulnerabilities",
              "priority": 3
            }
          ]
        },
        "categorization": {
          "product_issues": [],
          "conduct_issues": [],
          "tags": [],
          "patterns": {}
        }
      },
      "metadata": {
        "analysis_timestamp": "2025-01-06T08:01:53.053793",
        "data_confidence": 80,
        "pattern_confidence": null
      }
    }
  ]
}